Astiazaran-Symonds, E.; Kim, J.; Haley, J.S.; Kim, S.Y.; Rao, H.S.; Genetics Center, R.; Carey, D.J.; Stewart, D.R.; Goldstein, A.M.
A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. Cancers 2022, 14, 3257.
https://doi.org/10.3390/cancers14133257
AMA Style
Astiazaran-Symonds E, Kim J, Haley JS, Kim SY, Rao HS, Genetics Center R, Carey DJ, Stewart DR, Goldstein AM.
A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. Cancers. 2022; 14(13):3257.
https://doi.org/10.3390/cancers14133257
Chicago/Turabian Style
Astiazaran-Symonds, Esteban, Jung Kim, Jeremy S. Haley, Sun Young Kim, H. Shanker Rao, Regeneron Genetics Center, David J. Carey, Douglas R. Stewart, and Alisa M. Goldstein.
2022. "A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes" Cancers 14, no. 13: 3257.
https://doi.org/10.3390/cancers14133257
APA Style
Astiazaran-Symonds, E., Kim, J., Haley, J. S., Kim, S. Y., Rao, H. S., Genetics Center, R., Carey, D. J., Stewart, D. R., & Goldstein, A. M.
(2022). A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. Cancers, 14(13), 3257.
https://doi.org/10.3390/cancers14133257